Jump to content

MedAustron

Edit links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Onel5969 (talk | contribs) at 02:33, 22 October 2023 (→History: clean up, typo(s) fixed: 1990's → 1990s). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

MedAustron in Wiener Neustadt (2015)

MedAustron is an interdisciplinary and supra-regional Austrian center for cancer treatment with particle therapy, research and further development of this form of therapy, and non-clinical research with protons and heavier ions.

History

In the early 1990s, as part of the Austron project by an organization of the same name, there was a plan to establish a neutron spallation source as a major research facility for particle radiation in Austria. MedAustron was conceived in parallel from the late 1990s.[1] In 1996, with the financial support of the City of Wiener Neustadt and the Province of Lower Austria, a base was created in the form of an office in the Regional Innovation Center (RIZ), where essential parts of a three-volume feasibility study[2][3][4] were elaborated. This formed the basis of the subsequent design study,[5] which was published in 2004.

In 2012 the building was completed and in the following year the construction of the particle accelerator and the positioning system[6] started. In January 2013, the first ion source was inaugurated.[7] In parallel, the project was submitted to the Court of Auditors.[8] The technical trial operation and installation of the medical technology took place from 2014, and the medical physics commissioning in 2015.[9]

In August 2016, the irradiation room, including the proton beam, was officially handed over to the scientific community.[10][11]

On December 5, 2016, the first tumor patient was originally to have been treated. However, due to missing approvals, this date had to be postponed.[12] On December 14, 2016, the last missing certification took place; thus, the legally binding authorization for use was granted and the first tumor patients could be treated.[13]

In mid-2017, the second treatment room was put into operation.[14] In July 2019, it was possible to start working with carbon ions for the first time.[15] In 2022, Ludwig Gold succeeded Alfred Zens as managing director.[16]

Professorships

In cooperation with the Medical University of Vienna and the Vienna University of Technology, a total of three professorships were created in 2014 and 2015. These include the two professorships "Medical Radiation Physics and Oncotechnology" and "Applied and Translational Radiation Biology" at the Medical University of Vienna. At the Atomic Institute of the Vienna University of Technology, a separate professorship was established in the Radiation Physics Group.[17][18]

References

  1. ^ "Rückblick und Jahresbericht 2009 des Vorstandes des Vereins AUSTRON" (PDF). info.tuwien.ac.at. Retrieved 2023-10-20.
  2. ^ R. Pötter, T. Auberger (1998), Med-AUSTRON Machbarkeitsstudie, Band I, Bedeutung der Hadronentherapie für die Krebsbehandlung, vol. Band I, Wr. Neustadt, p. 159, ISBN 3-9500952-0-9{{citation}}: CS1 maint: location missing publisher (link)
  3. ^ R. Pötter, T. Auberger, M. Regler, ed. (1998), Med-AUSTRON - Machbarkeitsstudie Der Med-AUSTRON Beschleuniger - ein europäisches Konzept zur Protonen- und Ionentherapie - Aspekte der Beschleunigerphysik und der Medizinphysik, vol. Band II, Wr. Neustadt, p. 249, ISBN 3-9500952-1-7{{citation}}: CS1 maint: location missing publisher (link) CS1 maint: multiple names: editors list (link)
  4. ^ R. Pötter, T. Auberger, M. Regler, ed. (1998), Med-AUSTRON - Machbarkeitsstudie, Band III, Konzept zur Realisierung eines österreichischen Hadronentherapiezentrums, vol. Band III, Wr. Neustadt, p. 204, ISBN 3-9500952-2-5{{citation}}: CS1 maint: location missing publisher (link) CS1 maint: multiple names: editors list (link)
  5. ^ T. Auberger, E. Griesmayr, T. Auberger, E. Griesmayr (ed.), Das Projekt MedAustron, Wr. Neustadt, p. 439, ISBN 3-200-00141-0
  6. ^ "Erster Positionierungsroboter für MedAustron". noe.orf.at (in German). 2013-08-23. Retrieved 2023-10-20.
  7. ^ "Feierliche Übergabe der Ionenquelle für MedAustron". OTS.at (in German). Retrieved 2023-10-20.
  8. ^ "Bericht des Rechnungshofes - Errichtung von MedAustron; Follow-up-Überprüfung" (PDF). rechnungshof.gv.at. Retrieved 2023-10-20.
  9. ^ "MedAustron startet Tests für Anlagenbewilligung - Medianet". medianet.at. 2016-12-20. Retrieved 2023-10-20.
  10. ^ "Start für die Forschung". www.noen.at (in German). 2016-08-24. Retrieved 2023-10-20.
  11. ^ natascha.marakovits (2016-08-20). "Kampf gegen Krebs: MedAustron für die Wissenschaftler geöffnet". kurier.at (in German). Retrieved 2023-10-20.
  12. ^ "MedAustron: Warten auf Zulassung". noe.orf.at (in German). 2016-12-05. Retrieved 2023-10-20.
  13. ^ Grass, Alexandra (2016-12-14). "Krebstherapie - Start frei für Partikeltherapie". Mensch - Wiener Zeitung Online (in German). Retrieved 2023-10-20.
  14. ^ "Alles läuft nach Plan bei MedAustron". MeinBezirk.at (in German). 2018-03-27. Retrieved 2023-10-20.
  15. ^ Grabner, Philipp (2019-07-23). "Neue Therapie im Kampf gegen Krebs". www.noen.at (in German). Retrieved 2023-10-20.
  16. ^ "Wiener Neustadt: neuer Geschäftsführer bei MedAustron". WN24 Wiener Neustadt News (in German). 2022-04-21. Retrieved 2023-10-20.
  17. ^ "Pressemappe Medaustron" (PDF). medaustron.at. Retrieved 2023-10-20.
  18. ^ Online, Wiener Zeitung (2011-09-28). "Mehr Forschung in Wiener Neustadt - TU Wien richtet am MedAustron zwei Professuren ein". Forschung - Wiener Zeitung Online (in German). Retrieved 2023-10-20.
Retrieved from "https://en.wikipedia.org/w/index.php?title=MedAustron&oldid=1181285447"